Covered recipient · General Payments record
ERIN CHARPENTIER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,320.51
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $237.88 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $53.52 | 2 |
| Corcept Therapeutics | $49.02 | 2 |
| DEXCOM, INC. | $44.51 | 2 |
| Xeris Pharmaceuticals, Inc. | $37.73 | 2 |
| Lilly USA, LLC | $20.12 | 1 |
| ABBVIE INC. | $16.97 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.97 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106904950 | CMS |
| Boston Scientific Corporation | $16.01 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092715098 | CMS |
| Corcept Therapeutics | $19.93 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117728020 | CMS |
| Corcept Therapeutics | $29.09 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117728084 | CMS |
| Dexcom, Inc. | $22.06 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153360591 | CMS |
| Dexcom, Inc. | $22.45 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153360593 | CMS |
| Lilly USA, LLC | $20.12 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135658599 | CMS |
| Novo Nordisk Inc | $39.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100450792 | CMS |
| Novo Nordisk Inc | $14.25 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100333337 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.08 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144625943 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.65 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144625945 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.